Cancer Diagnostics Market to reach by 2040
Overview of the Cancer Diagnostics Market
Roots Analysis has published a report on the global Cancer Diagnostics market, This market research report delivers a detailed and up-to-date analysis of the industry, covering market size, share, growth trends, key drivers, restraints, opportunities, and competitive landscape. Designed for business leaders, investors, and analysts, the report provides actionable intelligence to support strategic planning, market entry decisions, and long-term investment strategies.
Key Findings of the Study:
In terms of geographical regions, North America currently holds the highest atrial fibrillation treatment devices market share ( nearly 50%) .
Market Size in 2026: $9.6 Billion
Estimated Market Size in 2035: $29.0 Billion
CAGR (2026-2035): 13.1%
North America: Largest market in 2026
Asia-Pacific: Fastest growing region
- To know more about other segments within Cancer Diagnostics market, read here https://www.rootsanalysis.com/reports/cancer-diagnostics-market.html
Cancer Diagnostics Adoption in the Asia Pacific Region
Request for free sample, https://www.rootsanalysis.com/reports/cancer-diagnostics-market/request-sample.html
Competitive Landscape
The Cancer Diagnostics Market has multiple key players in the market, which are profiled in the report also-
- Abbott
- Agilent
- Astellas
- BD
- Bio-Rad
- bioMérieux
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- GE Healthcare
- Genomic Health
- GSK
- Hologic
- Illumina
- Philips
- Lilly
- Merck
- Myriad
- Novartis
- Pfizer
- QIAGEN
- Quest
- Roche
- R. Bard
- Siemens
- Thermo Fisher Scientific
- Toshiba Medical Systems
There are more key players involved in Cancer Diagnostics market mentioned in the report
Key Market Segments
Cancer Diagnostics Market Segmentation Insights
The market research report presents an in-depth analysis of the various companies that are engaged in providing consumables and instruments for cancer diagnostics across different segments, as defined in the table below:
Cancer Diagnostics Market: Report Attributes / Market Segmentations
(A complete list of key companies captured is available in the report)
The key objective of the market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for companies active in this market during the forecast period. We have provided an informed estimate of the likely evolution of the market in the short to mid-term and long-term for the period till 2032. In addition, we have segmented the future opportunity across [A] types of products (consumables and instruments), [B] types of cancer diagnostics (testing type and technology), [C] types of indication, [D] type of end users, and [E] different global regions (North America, Europe, Asia-Pacific, and the rest of the world).
To account for the uncertainties associated with the market and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base, and optimistic tracks of the market's evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market research report are in USD unless otherwise specified.
▪ Consumables
▪ Antibodies
▪ Kits & Reagents
▪ Probes
▪ Others
▪ Instruments
▪ Pathology-based Instruments
▪ Slide Staining Systems
▪ Tissue Processing Systems
▪ Cell Processors
▪ PCR Instruments
▪ NGS Instruments
▪ Microarrays
▪ Other Pathology-based Instruments
▪ Imaging Instruments
▪ CT Systems
▪ Ultrasound Systems
▪ MRI Systems
▪ Mammography Systems
▪ Nuclear Imaging Systems
▪ Biopsy Instruments
▪ Testing Type
▪ Biopsy
▪ Bone Marrow Biopsy
▪ Endoscopic Biopsy
▪ Fine-needle Aspiration
▪ Liquid Biopsy
▪ Needle Biopsy
▪ Skin Biopsy/Punch Biopsy
▪ Surgical Biopsy
▪ Endoscopy
▪ Genetic Tests
▪ Imaging Tests
▪ Laboratory Tests
▪ Tumor Biomarker Tests
▪ AFP Tests
▪ ALK Tests
▪ BRCA Tests
▪ CA Tests
▪ CEA Tests
▪ CTC Tests
▪ EGFR Mutation Tests
▪ HER2 Tests
▪ KRAS Mutation Tests
▪ PSA Tests
▪ Others
▪ Technology
▪ Flow Cytometry
▪ Immunoassays
▪ Immunohistochemistry (IHC)
▪ In Situ Hybridization (ISH)
▪ Microarrays
▪ Next-Generation Sequencing (NGS)
▪ Polymerase Chain Reaction (PCR)
▪ Other IVD Testing Technologies
▪ Blood Cancer
▪ Breast Cancer
▪ Colorectal Cancer
▪ Cervical Cancer
▪ Kidney Cancer
▪ Liver Cancer
▪ Lung Cancer
▪ Melanoma
▪ Ovarian Cancer
▪ Pancreatic Cancer
▪ Prostate Cancer
▪ Skin Cancer
▪ Stomach Cancer
▪ Others
▪ Diagnostic Imaging Centers
▪ Hospitals and Clinics
▪ Research Institutes
▪ Diagnostic Laboratories
▪ Others
▪ North America
▪ US
▪ Canada
▪ Mexico
▪ Europe
▪ Austria
▪ Belgium
▪ Denmark
▪ France
▪ Germany
▪ Ireland
▪ Italy
▪ Netherlands
▪ Norway
▪ Russia
▪ Spain
▪ Sweden
▪ Switzerland
▪ UK
▪ Other European countries
▪ Asia
▪ China
▪ India
▪ Japan
▪ Singapore
▪ South Korea
▪ Other Asian countries
▪ Latin America
▪ Brazil
▪ Chile
▪ Colombia
▪ Venezuela
▪ Other Latin American countries
▪ Middle East and North Africa Egypt
▪ Iran
▪ Iraq
▪ Israel
▪ Kuwait
▪ Saudi Arabia
▪ UAE
▪ Other MENA countries
▪ Rest of the World
▪ Australia
▪ New Zealand
▪ Other countries
▪ Abbott
▪ Agilent
▪ Astellas
▪ BD
▪ Bio-Rad
▪ bioMérieux
▪ Bristol-Myers Squibb
▪ F. Hoffmann-La Roche
▪ GE Healthcare
▪ Genomic Health
▪ GSK
▪ Hologic
▪ Illumina
▪ Philips
▪ Lilly
▪ Merck
▪ Myriad
▪ Novartis
▪ Pfizer
▪ QIAGEN
▪ Quest
▪ Roche
▪ R. Bard
▪ Siemens
▪ Thermo Fisher Scientific
▪ Toshiba Medical Systems
Key Questions Answered in the Report-
What are cancer diagnostics?
What is the market size of cancer diagnostics?
What is the projected market size of cancer diagnostics in 2032?
What is the CAGR for cancer diagnostics market?
Which region is leading the market for cancer diagnostics?
Which indication segment is leading the market for cancer diagnostics?
What are some public cancer diagnostic companies?
To read more about key questions answered and market insights, you can refer to the full report by Roots Analysis, https://www.rootsanalysis.com/reports/cancer-diagnostics-market.html
To learn more about this report, request a free sample copy
